Ensign Peak Advisors, Inc Myriad Genetics Inc Transaction History
Ensign Peak Advisors, Inc
- $56.1 Billion
- Q3 2024
A detailed history of Ensign Peak Advisors, Inc transactions in Myriad Genetics Inc stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 31,606 shares of MYGN stock, worth $403,608. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,606
Previous 31,606
-0.0%
Holding current value
$403,608
Previous $773,000
11.9%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding MYGN
# of Institutions
248Shares Held
91MCall Options Held
100KPut Options Held
34K-
Black Rock Inc. New York, NY15.2MShares$193 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.3MShares$132 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA6.72MShares$85.8 Million0.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.18MShares$66.1 Million0.07% of portfolio
-
State Street Corp Boston, MA4.7MShares$60.1 Million0.01% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $1.03B
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...